Global Hepatitis Vaccine Market Size, by Type (Hepatitis A, Hepatitis B, Hepatitis C), by Route of Administration (Oral, Injectable) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1121958
  • |
  • Date : July-2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Hepatitis Vaccine Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Growing occurrence of viral hepatitis together with the rise in the number of autoimmune disease will help in boosting the market growth. In addition, surge in healthcare expenditures across the globe might also create lucrative opportunities for key market players. Conversely, the availability of hepatitis drugs in developing economies might be a key restraint for the market.

The global hepatitis vaccine market is primarily segmented based on type, route of administration and regions.

On the basis of type, the market is split into:
* Hepatitis A
* Hepatitis B
* Hepatitis C

On the basis of route of administration, the market is split into:
* Oral
* Injectable

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Gilead Lifesciences
* Bristol-Myers Squibb Co
* Biocon
* AbbVie
* Merck & Co., Inc.,
* Johnson & Johnson
* Glaxosmithkline Plc
* Sanofi
* Novartis
* Seqirus

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, type, route of administration and market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions type, route of administration and options with qualitative and quantitative information and facts

Target Audience:
* Hepatitis Vaccine Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Hepatitis Vaccine Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Hepatitis Vaccine Market - Porter\'s Five Forces Analysis
4.4. Global Hepatitis Vaccine Market - PESTEL Analysis

5. Global Hepatitis Vaccine Market, by Type
5.1. Global Hepatitis Vaccine Market, Size and Forecast, 2015-2026
5.2. Global Hepatitis Vaccine Market, by Hepatitis A, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Hepatitis Vaccine Market, by Hepatitis B, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Hepatitis Vaccine Market, by Hepatitis C, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026

6. Global Hepatitis Vaccine Market, by Route of Administration
6.1. Global Hepatitis Vaccine Market, Size and Forecast, 2015-2026
6.2. Global Hepatitis Vaccine Market, by Oral, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Hepatitis Vaccine Market, by Injectable, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026

7. Global Hepatitis Vaccine Market by Region
7.1. Hepatitis Vaccine Market Regional Analysis, 2015-2026
7.2. Global Hepatitis Vaccine Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Hepatitis Vaccine Market, 2015-2026
7.3.1. North America Hepatitis Vaccine Market Size and Forecast, 2015-2026
7.3.2. North America Hepatitis Vaccine Market by Country, 2015-2026
7.3.2.1. U.S. Hepatitis Vaccine Market, 2015-2026
7.3.2.2. Canada Hepatitis Vaccine Market, 2015-2026
7.4. Europe Hepatitis Vaccine Market, 2015-2026
7.4.1. Europe Hepatitis Vaccine Market Size and Forecast, 2015-2026
7.4.2. Europe Hepatitis Vaccine Market by Country, 2015-2026
7.4.2.1. Germany Hepatitis Vaccine Market, 2015-2026
7.4.2.2. France Hepatitis Vaccine Market, 2015-2026
7.4.2.3. Italy Hepatitis Vaccine Market, 2015-2026
7.4.2.4. UK Hepatitis Vaccine Market, 2015-2026
7.4.2.5. Spain Hepatitis Vaccine Market, 2015-2026
7.4.2.6. Rest of Europe Hepatitis Vaccine Market, 2015-2026
7.5. Asia Pacific Hepatitis Vaccine Market, 2015-2026
7.5.1. Asia Pacific Hepatitis Vaccine Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Hepatitis Vaccine Market by Country, 2015-2026
7.5.2.1. Japan Hepatitis Vaccine Market, 2015-2026
7.5.2.2. China Hepatitis Vaccine Market, 2015-2026
7.5.2.3. India Hepatitis Vaccine Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Hepatitis Vaccine Market, 2015-2026
7.6. South America Hepatitis Vaccine Market, 2015-2026
7.6.1. South America Hepatitis Vaccine Market Size and Forecast, 2015-2026
7.6.2. South America Hepatitis Vaccine Market by Country, 2015-2026
7.6.2.1. Mexico Hepatitis Vaccine Market, 2015-2026
7.6.2.2. Brazil Hepatitis Vaccine Market, 2015-2026
7.6.2.3. Rest of South America Hepatitis Vaccine Market, 2015-2026
7.7. Middle East & Africa Hepatitis Vaccine Market, 2015-2026
7.7.1. Middle East & Africa Hepatitis Vaccine Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Hepatitis Vaccine Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Hepatitis Vaccine Market, 2015-2026
7.7.2.2. South Africa Hepatitis Vaccine Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Hepatitis Vaccine Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2018

9. Company Profiles
9.1. Gilead Lifesciences
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. Bristol-Myers Squibb Co
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Biocon
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. AbbVie
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. Merck & Co., Inc.
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. Johnson & Johnson
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Glaxosmithkline Plc
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Sanofi
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
9.9. Novartis
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Product Benchmarking
9.9.4. Key Developments
9.10. Seqirus
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Product Benchmarking
9.10.4. Key Developments

10. Key Insights

Content are not available

Choose License Type